Prostate cancer therapy with high-intensity focused ultrasound.
High-intensity focused ultrasound (HIFU) has been used to ablate benign and malignant prostate tissue for several decades. This review summarizes the technology and available clinical trials to date. Continued technological advances combined with well-designed clinical trials could allow HIFU to become part of the arsenal against prostate cancer.
Gardner
Thomas A
TA
Department of Urology, Indiana University Medical Center, Indianapolis 46202, USA. thagardn@iupui.edu
Koch
Michael O
MO
D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000000981:diagnostic imaging* / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy*; D014464:Ultrasonic Therapy; D014463:Ultrasonography